Characterization of Follicular T Helper Cells and Donor-specific T Helper Cells in Renal Transplant Patients with De Novo Donor-specific HLA-antibodies
Overview
Authors
Affiliations
T follicular helper (T) cells are a heterogeneous subset of immunocompetent T helper (T) cells capable of augmenting B cell responses in lymphoid tissues. In transplantation, exposure to allogeneic tissue activates T cells increasing the risk of the emergence of de novo donor-specific HLA-antibodies (dnDSA). These can cause antibody-mediated rejection (AMR) and allograft loss. Follicular regulatory T (T) cells counteract T cell activity. Here, we investigated the implications of T and T cells on dnDSA formation after renal transplantation (RTX). Considering T cells to be CXCR5 and IL-21, we found by flow cytometry that patients with dnDSA produced IL-21 more abundantly compared to healthy volunteers. In in vitro alloreactivity assays, patients with dnDSA featured an enhanced alloreactive T cell pool in response to donor-specific HLA antigens. Besides, longitudinal investigations suggested enhanced alloreactivity shortly after transplantation increasing the risk of dnDSA development. Taken together, in spite of continuous immunosuppression we report a strong IL-21 response in T cells and an expanded reservoir of donor-specific memory T cells in patients with dnDSA. This warrants further investigations if aberrant T cell activation may precede the formation of dnDSA promoting AMR.
Desy O, Beland S, Thivierge M, Marcoux M, Desgagnes J, Bouchard-Boivin F Front Immunol. 2024; 15:1275933.
PMID: 38384450 PMC: 10879567. DOI: 10.3389/fimmu.2024.1275933.
Kandalla P, Subburayalu J, Cocita C, de Laval B, Tomasello E, Iacono J EMBO Mol Med. 2023; 15(11):e17694.
PMID: 37635627 PMC: 10630876. DOI: 10.15252/emmm.202317694.
Subburayalu J Front Immunol. 2023; 14:1114842.
PMID: 37503334 PMC: 10368994. DOI: 10.3389/fimmu.2023.1114842.
Adaptive immune cell responses as therapeutic targets in antibody-mediated organ rejection.
Louis K, Macedo C, Lefaucheur C, Metes D Trends Mol Med. 2022; 28(3):237-250.
PMID: 35093288 PMC: 8882148. DOI: 10.1016/j.molmed.2022.01.002.